ARCHIVES

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

This article is from The Cancer Letter archive.

Vol. 06 No. 21 | May 23, 1980

Download PDF Visit The Full Archive

Related Articles

NCI’s Hawk To Lead Prevention Division At M.D. Anderson.

November 16, 2007

In Brief: Brian Henderson Names New Director Of USC Comprehensible Cancer Center, Norris Hospital

April 8, 1983

In Brief: Pazdur to direct FDA Oncology Division; Ganz Awarded ACS Clinical Professorship

July 23, 1999

Carcinogenesis Testing Moved Out of DCCP To New Status As Division, Giving Rall More Authority

September 14, 1979

NIH Authorization Set For Another Try; Women’s Cancers Are Targeted

July 10, 1992

White House Gives FDA Authority Over Tobacco Product Sales

August 18, 1995